Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non-small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing

By sjmartinez • September 22, 2024

Lee JM. Neoadjuvant, perioperative, or adjuvant immunotherapy in resectable non-small cell lung cancer: How do I choose? Importance of immune biomarkers and molecular testing. J Thorac Cardiovasc Surg. 2024 Oct;168(4):1281-1288. doi: 10.1016/j.jtcvs.2024.03.034. Epub 2024 Apr 20. PMID: 38649111.

Tags: Adjuvant, immunotherapy, Lung cancer, neoadjuvant, NSCLC, Perioperative, Publications, Pulmonary, Critical Care & Sleep Medicine

The Association Between Adverse Childhood Experiences and Health-Related School Absenteeism: Results From a National Survey of Youth

Tsevat RK, Nkansah MM, Shankar M, Choi K, Jackson NJ, Thyne SM, Gordon B, Dudovitz RN. The Association Between Adverse Childhood Experiences and Health-Related School[...]

RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC

Nishio M, Seto T, Reck M, Garon EB, Nishio K, Kasahara K, Nishino K, Satouchi M, Yoh K, Hayashi H, Sakai K, Enatsu S, Matsui[...]

Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis, Fatigue, and Treatment With Avacopan: A Case Series

Schulze C. Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis, Fatigue, and Treatment With Avacopan: A Case Series. Cureus. 2025 Oct 20;17(10):e94987. doi: 10.7759/cureus.94987. PMID: 41280980; PMCID: PMC12631709.